These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38636973)

  • 1. "Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial." F. Torres, H. Farber, A. Ristic,
    Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38636973
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial.
    Torres F; Farber H; Ristic A; McLaughlin V; Adams J; Zhang J; Klassen P; Shanahan W; Grundy J; Hoffmann I; Cabell C; Escribano Subías P; Sood N; Keogh A; D'Souza G; Rubin L
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31391223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers.
    Grundy JS; King CD; Adams JW; Cabell CH
    Pulm Circ; 2020; 10(2):2045894020922814. PubMed ID: 32489643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Airway smooth muscle area to predict steroid responsiveness in COPD patients receiving triple therapy (HISTORIC): a randomised, placebo-controlled, double-blind, investigator-initiated trial." D. Stolz, E. Papakonstantinou, M. Pascarella,
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37827551
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific genetic inhibition of nuclear factor-κB prevents right ventricular hypertrophy induced by monocrotaline.
    Kumar S; Wei C; Thomas CM; Kim IK; Seqqat R; Kumar R; Baker KM; Jones WK; Gupta S
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1655-66. PubMed ID: 22245771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial.
    Rangnekar H; Patankar S; Suryawanshi K; Soni P
    Trials; 2020 Nov; 21(1):943. PubMed ID: 33225970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol.
    Calderone A; Stevens W; Prior D; Nandurkar H; Gabbay E; Proudman SM; Williams T; Celermajer D; Sahhar J; Wong PK; Thakkar V; Dwyer N; Wrobel J; Chin W; Liew D; Staples M; Buchbinder R; Nikpour M
    BMJ Open; 2016 Dec; 6(12):e011028. PubMed ID: 27932335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activation." M. Schicht, F. Rausch, S. Finotto,
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237999
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Simpson EL; Sinclair R; Forman S; Wollenberg A; Aschoff R; Cork M; Bieber T; Thyssen JP; Yosipovitch G; Flohr C; Magnolo N; Maari C; Feeney C; Biswas P; Tatulych S; Valdez H; Rojo R
    Lancet; 2020 Jul; 396(10246):255-266. PubMed ID: 32711801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator." M.J. Divo, C. Liu, F. Polverino,
    Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37857431
    [No Abstract]   [Full Text] [Related]  

  • 12. Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trial.
    Zhan Y; Lin Z; Liang J; Sun R; Li Y; Lin B; Ge F; Lin L; Lu H; Su L; Xiang T; Pan H; Huang C; Deng Y; Wang F; Xu R; Chen D; Zhang P; Tong J; Wang X; Meng Q; Zheng Z; Ou S; Guo X; Yao H; Yu T; Li W; Zhang Y; Jiang M; Fang Z; Song Y; Chen R; Luo J; Kang C; Liang S; Li H; ; Zheng J; Zhong N; Yang Z
    EClinicalMedicine; 2024 Jan; 67():102359. PubMed ID: 38188690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Rosenkranz S; Feldman J; McLaughlin VV; Rischard F; Lange TJ; White RJ; Peacock AJ; Gerhardt F; Ebrahimi R; Brooks G; Satler C; Frantz RP;
    Lancet Respir Med; 2022 Jan; 10(1):35-46. PubMed ID: 34425071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Asthma and incident coronary heart disease: an observational and Mendelian randomisation study." C.A. Valencia-Hernández, F. Del Greco M, V. Sundaram,
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38548275
    [No Abstract]   [Full Text] [Related]  

  • 17. "Age-related changes in plasma biomarkers and their association with mortality in COVID-19." E.H.A. Michels, B. Appelman, J. de Brabander,
    Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38423593
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of montelukast-desloratadine combination on early and late asthma responses Davis BE, Illamperuma C, Gauvreau GM, et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009;33(6):1302-308.
    Antoniu SA
    Expert Opin Pharmacother; 2009 Oct; 10(15):2577-9. PubMed ID: 19735214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial.
    Ji L; Gao L; Jiang H; Yang J; Yu L; Wen J; Cai C; Deng H; Feng L; Song B; Ma Q; Qian L
    EClinicalMedicine; 2022 Dec; 54():101691. PubMed ID: 36247927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.